| UHC UMR Medical and Drug | Itvisma® (Onasemnogene Abeparvovec-Brve) – Commercial and Individual Exchange Medical Benefit Drug Policy | 2026-10-01 |
| UHC Commercial Medical & Drug | Itvisma® (Onasemnogene Abeparvovec-Brve) – Commercial and Individual Exchange Medical Benefit Drug Policy | 2026-10-01 |
| Anthem Blue Cross | Transcatheter Mitral, Pulmonary, and Tricuspid Heart Valve Procedures | 2026-10-01 |
| Anthem Blue Cross | Transcatheter Aortic Heart Valve Procedures | 2026-10-01 |
| BCBS Highmark Delaware | Hemophilia Treatment Clotting Factors/Coagulant Blood Products | 2026-10-01 |
| BCBS Highmark Delaware | Denosumab (Prolia, Xgeva) and Denosumab Biosimilars | 2026-10-01 |
| UHC Medicaid Medical & Drug | Bronchial Thermoplasty – Community Plan Medical Policy | 2026-10-01 |
| UHC Medicaid Medical & Drug | Brow Ptosis and Eyelid Repair – Community Plan Medical Policy | 2026-10-01 |
| UHC Medicaid Medical & Drug | Buprenorphine (Brixadi® & Sublocade®) – Community Plan Medical Benefit Drug Policy | 2026-10-01 |
| UHC Medicaid Medical & Drug | Denied Drug Codes – Pharmacy Benefit Drugs (for Arizona Only) – Community Plan Medical Benefit Drug Policy | 2026-10-01 |